Vol 9, No 1- Neuropsychiatry and Cardiovascular Disease
Past issues Contributors How to publish Contributions and comments Home
 
Poster Cardiac adverse reactions associated with psychotropic drugs Sudden death A 10-year cohort study found a 1.33-fold relative risk of death in a schizophrenic population compared with a control population;the leading cause of death was car- diovascular disease.6In patients with myocardial infarc- tion and cardiac failure,reduced heart rate variability is one of the predictive factors of increased risk of cardiac death7;this reduced heart rate variability might be due to the anticholinergic effects of psychotropic drugs.8 Polymedication was also identified as an independent risk factor for death.6 Thioridazine,an old and widely prescribed neuroleptic drug which was recently withdrawn,was associated with 75% of 49 deaths in a patient group taking a single antipsychotic drug regimen;its potential for QT prolon- gation had already been reported in 1963.9,10Unexplained sudden death in young adults has been linked to the pre- scription of antipsychotics other than thioridazine.11 QT interval Electrocardiographic modifications due to psychotropic drugs include prolongation of the PQ interval (atrioven- tricular blocks of different degrees of severity),widening of the QRS interval (bundle branch block),ST-segment changes (repolarization disturbances),and prolongation of the QT interval. Drug-induced long QT syndrome is an underestimated adverse drug effect:morbidity and mortality associated with a prolongation of the QT interval currently consti- tute the most frequent cause of drug withdrawal from the market or “black-box”warning after marketing.12In 1920,Bazett found that the repolarization phase was related to ventricular systole,and that its duration was mainly influenced by the heart rate.13Bazett's formula corrects the QT interval with an approximation for a rate of 60/min as follows:QTc=QT/ RR,expressed in sec- onds (Figure 1). Copyright © 2007 LLS SAS. All rights reserved Rates of cardiovascular morbidity and mortality in psychiatric patients are higher than in the general population:it is estimated that those who suffer from schizophrenia have a life expectan- cy approximately 20% shorter than those who do not,and this difference is not fully accounted for by suicide or accidental death.1 Cardiovascular adverse effects of psychotropic drugs are common,and potentially harmful.2The most serious cardiovascular consequences of psy- chotropic drugs are arrhythmias and sudden death,which principally result from torsades de pointes following progressive QT interval prolongation.Less severe cardiac adverse drug reac- tions are extremely common.Orthostatic hypotension,vasodilatation with transient collapse,and reflex sinus tachycardia due to a1-adrenoceptor blockade and to anticholinergic effects occur at therapeutic dosages of several psychotropic drugs.Postural hypotension was found in 77% of patients receiving antipsychotic medication versus 15% receiving placebo,and a correlation was found with drug dosage.3Furthermore,antipsychotic drug use is associated with an increased risk of hip fracture with a relative risk of 2 (confidence interval [CI],1.6 to 2.6) and accounts for a third of all falls in nursing homes.4,5